tweetindex
IT

Teva Pharmaceuticals

@TevaUSA · United States · joined 27 Aug 2010

We’re a leading innovative biopharmaceutical company, enabled by a world-class generics business. Guidelines: https://t.co/sOC1rpJ9tr

10 797Followers
1 043Following
3 378Posts total
26.1KViews on collected posts

Ultimi post

#Breaking: Teva announces positive topline results from phase 2a study in celiac disease for its anti-il-15 antibody, further validating its pipeline-in-a-product potential. Join the webcast today at 8:00 am ET: https://t.co/pQ5MvE6hv4 Read the press release: https://t.co/D5aHHyE 348 views · 8 likes · 3 reposts · 0 replies Open on X →
The @US_FDA has accepted Teva’s NDA and granted Priority Review for a potential new treatment option for pediatric patients living with #TouretteSyndrome. Learn more here: https://t.co/wR6XdLb0ve #PivotToGrowth $Teva https://t.co/ey1mWcJNii 370 views · 6 likes · 1 reposts · 0 replies Open on X →
@TevaUSA Looks like the Israeli cat is out of the genocidal bag. 28 views · 0 likes · 0 reposts · 0 replies Open on X →
Drug giant asks US judge to bar references to its Israeli origin at trial —— Teva Pharmaceuticals has asked a US judge to bar insurer Humana from telling jurors that the company is Israeli during a major drug price-fixing trial, arguing that public sentiment surrounding the https 24.1K views · 385 likes · 266 reposts · 20 replies Open on X →
Our Q2 2026 earnings call is starting in 30 minutes. Join CEO Richard Francis live to hear about Teva's business performance and plans ahead. https://t.co/8Yp7CEi3bC Forward-looking statements are subject to the cautionary note included in our Q2 2026 press release. https://t.co/ 337 views · 3 likes · 0 reposts · 5 replies Open on X →
We are reporting our Q2 2026 financial results, as we continue our transformation into a leading biopharma company https://t.co/KFrXj1Y2kO Forward-looking statements are subject to the cautionary note included in our Q2 2026 press release. #QuarterlyResults #Earnings $Teva https 561 views · 3 likes · 0 reposts · 1 replies Open on X →
Tune in to our Q2 2026 earnings call with CEO Richard Francis and the Teva leadership team on Wednesday, July 29. Save the date: https://t.co/tGfo70bWqo #QuarterlyResults #Q2Results #Earnings $Teva Forward-looking statements are subject to the cautionary note included in our Q2 330 views · 2 likes · 0 reposts · 0 replies Open on X →

Rispetto ad account della stessa dimensione

7 post degli ultimi 90 giorni, accanto alla fascia di 10K–100K follower. esattamente sulla mediana della sua fascia di follower.

Visualizzazioni mediane348questo account924mediana per 10K–100K
Copertura, %3.22%questo account3.62%mediana per 10K–100K
Interazione, %1.89%questo account1.52%mediana per 10K–100K
MetricaQuesto accountMediana per 10K–100KRapporto
Visualizzazioni mediane per post3489240.38×
Copertura (visualizzazioni ÷ follower)3.22%3.62%0.89×
Tasso di interazione1.89%1.52%1.24×

Altri account di questa fascia →   Confronta con un altro account →   Come sono costruiti questi parametri →

Growth & engagement

How the posts we collected actually performed: views and reaction rate post by post, what the audience did with them, and where the follower count goes.

Views per post

33022 Jul
56129 Jul
337
24.1K7 Aug
288 Aug
37019 Aug
3482 Sep

Last 7 collected posts, oldest on the left. The scale is logarithmic: one post can outrun the rest a hundred times over.

Engagement rate per post

0.61%22 Jul
0.89%29 Jul
2.37%
2.95%7 Aug
0.00%8 Aug
1.89%19 Aug
3.16%2 Sep

Reactions — likes, reposts, replies and quotes — divided by views. Median for 10K–100K accounts is 1.52%.

What the audience does

Likes54.6%407 in total
Reposts36.2%270 in total
Replies3.5%26 in total
Quotes5.6%42 in total

Share of every reaction we collected for this account. Replies mean argument, reposts mean endorsement, bookmarks mean the post was worth keeping.

Followers by day

4 Sep

Daily snapshots since 04 Sep 2026; the dashed line is the starting count.

Account simili